/term/non-interest-expense/FRA:PH7 PYC Therapeutics (FRA:PH7) Total Noninterest Expense
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (FRA:PH7) » Definitions » Total Noninterest Expense

PYC Therapeutics (FRA:PH7) Total Noninterest Expense


View and export this data going back to 2010. Start your Free Trial

What is PYC Therapeutics Total Noninterest Expense?

Total Noninterest Expense only applies to banks.

PYC Therapeutics (FRA:PH7) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PYC Therapeutics Ltd (FRA:PH7) » Definitions » Total Noninterest Expense
Comparable Companies
ASX:BOT ASX:OPT ASX:IMU ASX:IMM ASX:RAC ASX:DXB ASX:PIQ ASX:CUV ASX:ALA ASX:RCE OCSE:NOVO B VRTX REGN ASX:CSL MRNA XKRX:207940 XKRX:068270 XBRU:UCB BNTX XBRU:ARGX
Traded in Other Exchanges
PYC:Australia
Address
6 Verdun Street, Harry Perkins Institute of Medical Research, Nedlands, Perth, WA, AUS, 6009
Website
https://www.pyctx.com
PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the challenges in RNA therapeutics - safe and effective delivery of the drug inside the cell. The company's principal business activity is of of drug development and progressing the company's drug pipeline through preclinical and clinical development. Geographically, it operates only in Australia.